UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 14, 2021
Accession Number:
Submission Type:
CIK:
0001677077
Company Name:
Alzamend Neuro, Inc.
File Number:
333-255955